Clinical Trials on Volunteer Health Workers in Germany

Total 5891 results

Boehringer Ingelheim

Completed

Effect of Food on the Pharmacokinetics of BI 1060469 (Formulation Tablet) in Healthy Male Subjects

Healthy

Germany
Boehringer Ingelheim

Withdrawn

Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

Healthy

Germany
Bayer

Completed

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

Healthy

Germany
Boehringer Ingelheim

Completed

Effect of Repeated Doses of BI 1060469 and BI 1021958 on Glomerular Filtration Rate (GFR) in Healthy Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of Rifampicin

Healthy

Germany
Phenex Pharmaceuticals AG

Completed

Single Ascending Oral Dose Phase I Study With Px-102

Healthy

Germany
Phenex Pharmaceuticals AG

Completed

Multiple Ascending Oral Dose Phase I Study With Px-102

Healthy

Germany
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects

Healthy

Germany
Orion Corporation, Orion Pharma

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers (NOCOS)

Healthy

Germany
Boehringer Ingelheim

Completed

DDI Between BI Empagliflozin (10773) and Verapamil

Healthy

Germany
Boehringer Ingelheim

Completed

Drug Interaction Study of Digoxin and BI 10773

Healthy

Germany
Boehringer Ingelheim

Completed

Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components

Healthy

Germany
University of Luebeck
Novo Nordisk A/S

Completed

Liraglutide Effects on Memory in Healthy Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823

Healthy

Germany
Boehringer Ingelheim

Completed

Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food

Healthy

Germany
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 144807 Powder in Bottle in Healthy Male Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Relative Bioavailability of Bromhexine Given as Granules and Syrup in Healthy Volunteers (Clinical Phase I Study)

Healthy

Germany
Boehringer Ingelheim

Completed

Phase I Study of AbGn-168H in Healthy Male Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

Study to Explore Pharmacokinetics and Pharmacodynamics of a Single Rising Dose of BI 135585 XX

Healthy

Germany
Ludwig-Maximilians - University of Munich

Completed

Cheek Cells - Non-invasive Fatty Acid Status Marker

Healthy

Germany
Moberg Pharma AB

Completed

A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects (Limsafe)

Healthy

Germany
Orion Corporation, Orion Pharma

Completed

Pharmacokinetic Pilot Study on Budesonide/Formoterol

Healthy

Germany
CellMed AG, a subsidiary of BTG plc.

Completed

Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3.1-AC100 in Healthy Male Volunteers

Healthy

Germany
AstraZeneca

Completed

Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan)

Healthy

Germany
University Hospital Muenster

Terminated

Contraception in Normal and Subnormal Men

Healthy

Germany
Novartis

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

Healthy

Germany
Novartis

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

Healthy

Germany
Heidelberg University

Completed

Bioavailability and Metabolism of Voriconazole in Relation to Its Modulation by the CYP2C19 Genetic Polymorphism

Healthy

Germany
Avera Pharmaceuticals

Completed

The Efficacy and Safety of Gantacurium Chloride for Injection in Tracheal Intubation in Healthy Adult Patients Undergoing Surgery Under General Anesthesia

Healthy

Germany
Boehringer Ingelheim

Recruiting

A Study in Healthy People to Test How BI 1015550 is Taken up in the Body When Given With or Without Food

Healthy

Germany
Boehringer Ingelheim

Active, not recruiting

A Study in Healthy People to Test Whether Iclepertin Has an Effect on Cardiac Safety

Healthy

Germany
Boehringer Ingelheim

Completed

A Study to Test How Well Different Doses of BI 1584862 Are Tolerated by Healthy Men

Healthy

Germany
Boehringer Ingelheim

Completed

Safety Tolerability and Pharmacokinetic of BI 409306

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

Healthy

Germany
Boehringer Ingelheim

Completed

This Study in Healthy Men Tests How Different Doses of BI 894416 Are Taken up in the Body and How Well BI 894416 is Tolerated

Healthy

Germany
Boehringer Ingelheim

Completed

This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study)

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men and Women Who Are Either Between 18 - 45 Years or Between 65 - 80 Years to Test How Different Doses of BI 474121 Are Tolerated

Healthy

Germany
Boehringer Ingelheim

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men and Women to Test How Well Different Doses of BI 1323495 Are Tolerated

Healthy

Germany
Charite University, Berlin, Germany

Active, not recruiting

Physiological Response to 5 Days Fasting

Healthy

Germany
Boehringer Ingelheim

Completed

DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)

Healthy

Germany
Boehringer Ingelheim

Completed

Transporter Cocktail Mutual Interaction

Healthy

Germany
Boehringer Ingelheim

Completed

Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin

Healthy

Germany
University of Kiel

Completed

Impact of Protein Content of Ultraprocessed Foods on the Regulation of Energy Balance

Healthy

Germany
Boehringer Ingelheim

Completed

A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479

Healthy

Germany
Boehringer Ingelheim

Completed

Single Rising Dose Study of BI 690517 in Healthy Volunteers

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food

Healthy

Germany
Boehringer Ingelheim

Terminated

Evaluation of Safety and Tolerability of Single Rising Doses of BI 473494 in Healthy Subjects

Healthy

Germany
Boehringer Ingelheim

Completed

A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food

Healthy

Germany

3

Subscribe